1. Home
  2. HAE vs SKT Comparison

HAE vs SKT Comparison

Compare HAE & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • SKT
  • Stock Information
  • Founded
  • HAE 1971
  • SKT 1981
  • Country
  • HAE United States
  • SKT United States
  • Employees
  • HAE N/A
  • SKT N/A
  • Industry
  • HAE Medical/Dental Instruments
  • SKT Real Estate Investment Trusts
  • Sector
  • HAE Health Care
  • SKT Real Estate
  • Exchange
  • HAE Nasdaq
  • SKT Nasdaq
  • Market Cap
  • HAE 3.6B
  • SKT 3.8B
  • IPO Year
  • HAE 1991
  • SKT 1993
  • Fundamental
  • Price
  • HAE $62.98
  • SKT $35.82
  • Analyst Decision
  • HAE Strong Buy
  • SKT Buy
  • Analyst Count
  • HAE 9
  • SKT 9
  • Target Price
  • HAE $103.56
  • SKT $35.11
  • AVG Volume (30 Days)
  • HAE 1.4M
  • SKT 722.0K
  • Earning Date
  • HAE 02-06-2025
  • SKT 02-19-2025
  • Dividend Yield
  • HAE N/A
  • SKT 3.06%
  • EPS Growth
  • HAE 3.20
  • SKT N/A
  • EPS
  • HAE 2.54
  • SKT 0.88
  • Revenue
  • HAE $1,373,515,000.00
  • SKT $537,352,000.00
  • Revenue This Year
  • HAE $7.56
  • SKT N/A
  • Revenue Next Year
  • HAE $3.13
  • SKT $3.99
  • P/E Ratio
  • HAE $24.76
  • SKT $40.82
  • Revenue Growth
  • HAE 8.14
  • SKT 13.69
  • 52 Week Low
  • HAE $58.80
  • SKT $25.94
  • 52 Week High
  • HAE $97.97
  • SKT $37.57
  • Technical
  • Relative Strength Index (RSI)
  • HAE 38.28
  • SKT 66.01
  • Support Level
  • HAE $58.80
  • SKT $34.17
  • Resistance Level
  • HAE $65.15
  • SKT $36.76
  • Average True Range (ATR)
  • HAE 2.76
  • SKT 0.85
  • MACD
  • HAE 0.34
  • SKT 0.30
  • Stochastic Oscillator
  • HAE 32.85
  • SKT 78.49

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About SKT Tanger Inc.

Tanger Inc is a leading owner and operator of outlet and open-air retail shopping destinations. Tanger's portfolio of 38 outlet centers and one open-air lifestyle center comprises over 15 million square feet well positioned across tourist destinations and vibrant markets in U.S. states and Canada.

Share on Social Networks: